Who is sponsoring NCT05163548?

NCT05163548 is sponsored by Vivasure Medical Limited.

What drugs are being tested in NCT05163548?

Interventions in NCT05163548: PerQseal Plus Device.

What condition does NCT05163548 study?

NCT05163548 studies Percutaneous Large Hole Vascular Closure.

Is NCT05163548 still recruiting?

NCT05163548 is currently completed. Last updated 26 April 2023.

Last reviewed 2023-04-26 · How we verify

NCT05163548

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PerQseal®+ Early Feasibility Study

Completed NA Last updated 26 April 2023

What this trial tests

NA trial testing PerQseal Plus Device in Percutaneous Large Hole Vascular Closure in 15 participants. Completed in 7 July 2022.

Timeline

8 March 2022

Primary endpoint
7 July 2022

7 July 2022

Quick facts

Lead sponsor	Vivasure Medical Limited
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	8 March 2022
Primary completion	7 July 2022
Estimated completion	7 July 2022
Sites	5 locations across United States

Drugs / interventions tested

PerQseal Plus Device

Conditions studied

Percutaneous Large Hole Vascular Closure — all drugs for Percutaneous Large Hole Vascular Closure →

Sponsor

Vivasure Medical Limited

Who can join

19 and older, any sex, with Percutaneous Large Hole Vascular Closure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this Early Feasibility Study (EFS) is to evaluate the initial safety and preliminary effectiveness of the PerQseal®+ VCD in a small number of subjects when used to achieve hemostasis of common femoral arteriotomies created by 14 to 22 F sheaths (arteriotomy up to 26 F) in subjects undergoing Percutaneous Transcatheter procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Vivasure Medical Limited trials

Trials by the same sponsor.

NCT04818541 — PerQseal® Impella Early Feasibility Study · NA · completed
NCT04799769 — Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study · NA · unknown
NCT03423602 — Safety and Performance Study of Large Hole Vascular Closure Device FIV · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05163548 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vivasure Medical Limited
Last refreshed: 26 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05163548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing